FDA Approved: INCRUSE ELLIPTA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved Incruse Ellipta (umeclidinium) through an original application for the treatment of chronic obstructive pulmonary disease. This marks the approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Incruse Ellipta (umeclidinium bromide)

Snippet

ORIG AP for INCRUSE ELLIPTA (UMECLIDINIUM)